Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000020

Chief Medical Officer sold 7,000 shares at an average $32.37 ($226,559)

  • Chief Medical Officer acquired 7,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Goncalves Joana · Chief Medical Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-17 Exercise or conversion : show line 1 in the form 10b5-1 +3,500 $6.84 $23,940 37,518 D
2026-02-17 Exercise or conversion : show line 2 in the form 10b5-1 +3,500 $7.80 $27,300 41,018 D
2026-02-17 Sale : show line 3 in the form 10b5-1 −6,064 $32.30 $195,873 34,954 D
2026-02-17 Sale : show line 4 in the form 10b5-1 −936 $32.78 $30,686 34,018 D
Open-market sales · 7,000 sh · avg $32.37 · $226,559

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-02-17 Exercise or conversion : show line 5 in the form 10b5-1 Employee Stock Option (right to buy) −3,500 218,063 D
2026-02-17 Exercise or conversion : show line 6 in the form 10b5-1 Employee Warrant (right to buy) −3,500 189,492 D
Loading xslF345X05/form4.xml…